Monte Carlo-based 3-dimensional dosimetry of salivary glands in radioiodine treatment of differentiated thyroid cancer estimated using 124I PET (Q33682852)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Monte Carlo-based 3-dimensional dosimetry of salivary glands in radioiodine treatment of differentiated thyroid cancer estimated using 124I PET	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

28 July 2017

Monte Carlo-based 3-dimensional dosimetry of salivary glands in radioiodine treatment of differentiated thyroid cancer estimated using 124I PET (English)

1 reference

Europe PubMed Central

28 July 2017

differentiated thyroid carcinoma

1 reference

based on heuristic

inferred from title

Monte Carlo method

1 reference

based on heuristic

inferred from title

author name string

R F Hobbs

1

1 reference

Europe PubMed Central

28 July 2017

W Jentzen

2

1 reference

Europe PubMed Central

28 July 2017

A Bockisch

3

1 reference

Europe PubMed Central

28 July 2017

G Sgouros

4

1 reference

Europe PubMed Central

28 July 2017

publication date

1 March 2013

1 reference

Europe PubMed Central

28 July 2017

The Quarterly Journal of Nuclear Medicine and Molecular Imaging

1 reference

Europe PubMed Central

28 July 2017

57

1 reference

Europe PubMed Central

28 July 2017

79-91

1 reference

Europe PubMed Central

28 July 2017

1

1 reference

Europe PubMed Central

28 July 2017

Sialoadenitis secondary to ¹³¹I therapy for well-differentiated thyroid cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4037814

21 June 2018

Arterial wall dosimetry for non-Hodgkin lymphoma patients treated with radioimmunotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4037814

21 June 2018

Pre-therapeutic (124)I PET(/CT) dosimetry confirms low average absorbed doses per administered (131)I activity to the salivary glands in radioiodine therapy of differentiated thyroid cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4037814

21 June 2018

124I PET-based 3D-RD dosimetry for a pediatric thyroid cancer patient: real-time treatment planning and methodologic comparison

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4037814

21 June 2018

Calculation of the biological effective dose for piecewise defined dose-rate fits

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4037814

21 June 2018

MIRD pamphlet No. 20: the effect of model assumptions on kidney dosimetry and response--implications for radionuclide therapy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4037814

21 June 2018

Impact of late treatment-related toxicity on quality of life among patients with head and neck cancer treated with radiotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4037814

21 June 2018

Extension of the biological effective dose to the MIRD schema and possible implications in radionuclide therapy dosimetry

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4037814

21 June 2018

Partial-volume effect in PET tumor imaging

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4037814

21 June 2018

Three-dimensional radiobiologic dosimetry: application of radiobiologic modeling to patient-specific 3-dimensional imaging-based internal dosimetry

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4037814

21 June 2018

Partial-volume correction in PET: validation of an iterative postreconstruction method with phantom and patient data

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4037814

21 June 2018

Relationship between cumulative radiation dose and salivary gland uptake associated with radioiodine therapy of thyroid cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4037814

21 June 2018

Radioactive Iodine and the Salivary Glands

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4037814

21 June 2018

Molecular analysis of the sodium/iodide symporter: impact on thyroid and extrathyroid pathophysiology

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4037814

21 June 2018

MIRD pamphlet no. 16: Techniques for quantitative radiopharmaceutical biodistribution data acquisition and analysis for use in human radiation dose estimates

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4037814

21 June 2018

An immunohistochemical study of Na+/I- symporter in human thyroid tissues and salivary gland tissues

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4037814

21 June 2018

The linear-quadratic model and most other common radiobiological models result in similar predictions of time-dose relationships.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4037814

21 June 2018

Radiation dose to patients and relatives incident to 131I therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4037814

21 June 2018

The application of the linear-quadratic dose-effect equation to fractionated and protracted radiotherapy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4037814

21 June 2018

The linear-quadratic formula and progress in fractionated radiotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4037814

21 June 2018

Application of the linear-quadratic model with incomplete repair to radionuclide directed therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4037814

21 June 2018

Treatment of malignant thyroid disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4037814

21 June 2018

The influence of saliva flow stimulation on the absorbed radiation dose to the salivary glands during radioiodine therapy of thyroid cancer using 124I PET(/CT) imaging.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4037814

30 October 2018

(124)I positron emission tomography versus (131)I planar imaging in the identification of residual thyroid tissue and/or metastasis in patients who have well-differentiated thyroid cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4037814

30 October 2018

Experimental investigation of factors affecting the absolute recovery coefficients in iodine-124 PET lesion imaging.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4037814

30 October 2018

Botulinum toxin prevents radiotherapy-induced salivary gland damage.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4037814

30 October 2018

Optimized 124I PET dosimetry protocol for radioiodine therapy of differentiated thyroid cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4037814

30 October 2018

124-iodine positron emission tomography/computed tomography dosimetry in pediatric patients with differentiated thyroid cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4037814

30 October 2018

124I-PET dosimetry in advanced differentiated thyroid cancer: therapeutic impact.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4037814

30 October 2018

Partial volume effect compensation for quantitative brain SPECT imaging.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4037814

30 October 2018

Dose-volume modeling of salivary function in patients with head-and-neck cancer receiving radiotherapy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4037814

30 October 2018

Patient-specific dosimetry in predicting renal toxicity with (90)Y-DOTATOC: relevance of kidney volume and dose rate in finding a dose-effect relationship

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4037814

30 October 2018

The Dental Safety Profile of High-Dose Radioiodine Therapy for Thyroid Cancer: Long-Term Results of a Longitudinal Cohort Study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4037814

30 October 2018

(124)I in PET imaging: impact on quantification, radiopharmaceutical development and distribution

1 reference

https://pubmed.ncbi.nlm.nih.gov/23474639

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Salivary gland toxicity after radioiodine therapy for thyroid cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/23474639

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Differences among Monte Carlo codes in the calculations of voxel S values for radionuclide targeted therapy and analysis of their impact on absorbed dose evaluations

1 reference

https://pubmed.ncbi.nlm.nih.gov/23474639

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Salivary gland side effects commonly develop several weeks after initial radioactive iodine ablation

1 reference

https://pubmed.ncbi.nlm.nih.gov/23474639

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Scintigraphic evaluation of salivary gland dysfunction in patients with thyroid cancer after radioiodine treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/23474639

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combining dosimetry for targeted radionuclide and external beam therapies using the biologically effective dose

1 reference

https://pubmed.ncbi.nlm.nih.gov/23474639

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Radioisotope scanning of the salivary glands. A preliminary report

1 reference

https://pubmed.ncbi.nlm.nih.gov/23474639

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Radionuclide salivary gland imaging

1 reference

https://pubmed.ncbi.nlm.nih.gov/23474639

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Parotid gland function during and following radiotherapy of malignancies in the head and neck. A consecutive study of salivary flow and patient discomfort

1 reference

https://pubmed.ncbi.nlm.nih.gov/23474639

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Major salivary gland function in patients with radiation-induced xerostomia: flow rates and sialochemistry

1 reference

https://pubmed.ncbi.nlm.nih.gov/23474639

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

1 reference

Europe PubMed Central

28 July 2017

1 reference

Europe PubMed Central

28 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33682852&oldid=1609978521"